Sign In
Buy CNTB
$2.02
-0.0700 (-3.35%)
At Close: Jul 31, 2026
SAN DIEGO, CA and TAICANG, China, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmac
SAN DIEGO, CA and TAICANG, China, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmac
Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?
11:17am, Tuesday, 28'th Nov 2023
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and DexCom (DXCM) have performed compared to their sector so far this year.
Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
06:03am, Tuesday, 21'st Nov 2023
SAN DIEGO, CA and TAICANG, China, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmac
SAN DIEGO, CA and TAICANG, China, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmac
SAN DIEGO, CA and TAICANG, China, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmac
Is Connect Biopharma Holdings (CNTB) Outperforming Other Medical Stocks This Year?
11:18am, Monday, 06'th Nov 2023
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this year.
Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year?
11:18am, Friday, 20'th Oct 2023
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and Haemonetics (HAE) have performed compared to their sector so far this year.
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Friday, 15'th Sep 2023
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
04:15pm, Tuesday, 12'th Sep 2023
SAN DIEGO and TAICANG, China, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceut
Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
06:00am, Tuesday, 12'th Sep 2023
SAN DIEGO and TAICANG, China, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceut
Connect Biopharma to Participate in Upcoming September Investor Conferences
06:21pm, Thursday, 24'th Aug 2023
SAN DIEGO and TAICANG, China, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceuti
SAN DIEGO and TAICANG, China, July 10, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceuti
CNTB Stock Surges Over 20%: Explanation
10:41am, Monday, 20'th Mar 2023
The stock price of Connect Biopharma Holdings Ltd (NASDAQ: CNTB) surged by over 20% intraday today. This is why.
Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms
03:43pm, Saturday, 18'th Mar 2023
Late-Breaking Abstract and Oral Presentation at American Academy of Dermatology Annual Meeting Stage 1 of ongoing 52-week China pivotal AD trial met primary and secondary endpoints No efficacy plateau
